AU3347493A - Pharmaceutically active substituted benzimidazole derivatives - Google Patents

Pharmaceutically active substituted benzimidazole derivatives

Info

Publication number
AU3347493A
AU3347493A AU33474/93A AU3347493A AU3347493A AU 3347493 A AU3347493 A AU 3347493A AU 33474/93 A AU33474/93 A AU 33474/93A AU 3347493 A AU3347493 A AU 3347493A AU 3347493 A AU3347493 A AU 3347493A
Authority
AU
Australia
Prior art keywords
pharmaceutically active
benzimidazole derivatives
substituted benzimidazole
active substituted
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33474/93A
Inventor
Frans Eduard Janssens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU3347493A publication Critical patent/AU3347493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU33474/93A 1992-01-09 1992-12-29 Pharmaceutically active substituted benzimidazole derivatives Abandoned AU3347493A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92200041 1992-01-09
EP92200041 1992-01-09

Publications (1)

Publication Number Publication Date
AU3347493A true AU3347493A (en) 1993-08-03

Family

ID=8210355

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33474/93A Abandoned AU3347493A (en) 1992-01-09 1992-12-29 Pharmaceutically active substituted benzimidazole derivatives

Country Status (5)

Country Link
AU (1) AU3347493A (en)
IL (1) IL104347A0 (en)
TW (1) TW231291B (en)
WO (1) WO1993014083A1 (en)
ZA (1) ZA93144B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW531537B (en) * 1995-12-27 2003-05-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
EP1465635A4 (en) 2002-01-10 2005-04-13 Neurogen Corp Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
US7772232B2 (en) 2004-04-15 2010-08-10 Bristol-Myers Squibb Company Quinazolinyl compounds as inhibitors of potassium channel function
ES2350647T3 (en) 2005-03-08 2011-01-25 Janssen Pharmaceutica Nv DERIVATIVES OF DIAZA-ESPIRO- [4.4] -NONANO AS AN ANTHOGONIST OF NEUROQUININS (NK1).
US9550737B2 (en) 2012-06-11 2017-01-24 Ucb Biopharma Sprl TNF -α modulating benzimidazoles
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
US4908372A (en) * 1988-10-13 1990-03-13 Merrell Dow Pharmaceuticals Inc. Antihistaminic piperidinyl benzimidazoles
GB8900380D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives

Also Published As

Publication number Publication date
TW231291B (en) 1994-10-01
IL104347A0 (en) 1993-05-13
WO1993014083A1 (en) 1993-07-22
ZA93144B (en) 1994-07-08

Similar Documents

Publication Publication Date Title
AU6062590A (en) Pharmaceutically active compounds
AU3296893A (en) Benzimidazolyl derivatives
AU4123793A (en) Benzimidazole derivatives
AU3679693A (en) Benzimidazoles
AU3347493A (en) Pharmaceutically active substituted benzimidazole derivatives
GB9216962D0 (en) Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9203265D0 (en) Pharmaceutically active compound
AU4948093A (en) Benzimidazole derivatives as microbicides
HK37795A (en) Pharmaceutically active dithioketene derivatives
AU3030392A (en) Pharmacologically active tricyclic derivatives
AU4701993A (en) Pharmacologically active glycerophosphoderivatives
GB2284602B (en) Pharmaceutically active diketopiperazines
AU5886390A (en) Pharmaceutically active derivative delivery systems
GB9206862D0 (en) Pharmaceutically active compound
HRP921248B1 (en) New pharmacologically active catehol derivatives
GB9226974D0 (en) Pharmaceutically active compounds
GB9211596D0 (en) Pharmaceutically active compounds
GB9213597D0 (en) Pharmaceutically active compounds
GB9220761D0 (en) Pharmaceutically active compounds
GB9210639D0 (en) Pharmaceutically active compounds
GB9211787D0 (en) Pharmaceutically active compounds
AU639216B2 (en) Pharmaceutically active CNS compounds
AU639216C (en) Pharmaceutically active CNS compounds
SG171194G (en) Pharmaceutically active dithioketene derivatives
NO950530D0 (en) Pharmaceutically active diketopiperazines